tirzepatide osa fda approval The has expanded the of Eli Lilly's obesity medication Zepbound to include treating moderate to severe obstructive sleep apnea for people with obesity — the first medication approved for the What clinicians should know about

This process can compromise physical performance, slow down metabolism, and reduce overall resilience

Many patients continue for 1224+ months to reach and hold their goal

This stool can look like rabbit pellets or small pieces of stool, whereas the desired consistency of your poop is one long smooth snake

One common question patients ask is: can I switch from tirzepatide to semaglutide

Updated May 16, 2026 Reviewed by Lybi Ma Key points GLP-1 receptor agonists arent just for diabetes or obesitythey may treat cannabis abuse disorder

Already, Novo Nordisk is engaged in a patent dispute initiated by Huadong Medicine the pharmaceutical behemoth seeking to launch a Chinese rival to Ozempic